Search - tctmd.com

Displaying 601 - 620 of 1248

Sort: Relevancy | Date

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

COVID-19: TCTMD’s Daily Dispatch

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May

May 01, 2020

TCTMD’s Top 10 Most Popular Stories for April 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

May 01, 2020

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

April 29, 2020

Remdesivir Study for COVID-19 Yields Positive Top-line Results

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

News Daily News

Takotsubo Snapshot Reveals Some Surprises: InterTAK Registry

Yael L. Maxwell

April 27, 2020

An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19

News Features

An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19

April 14, 2020

Aspirin Okay for Up to 30 Days

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

April 03, 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

COVID-19: TCTMD’s Daily Dispatch

News Daily News

COVID-19: TCTMD’s Daily Dispatch for April

April 01, 2020

TCTMD’s Top 10 Most Popular Stories for March 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2020

April 01, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

News Daily News

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

March 09, 2020

Retrospective Analysis Isolates Predictors of Late Pacemaker Need Post-TAVR

News Conference News CRT 2020

Retrospective Analysis Isolates Predictors of Late Pacemaker Need Post-TAVR

March 06, 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

News Conference News CRT 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

March 03, 2020

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

TCTMD’s Top 10 Most Popular Stories for February 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

March 02, 2020

COVID-19: TCTMD’s Daily Dispatch

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March

March 01, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.